BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 17027182)

  • 21. [Profile and sensitivity to antibiotics of 2063 uropathogenic bacteria isolated in the center of Tunisia].
    Boukadida J; Boukadida N; Elraii S
    Bull Soc Pathol Exot; 2002 Mar; 95(1):8-10. PubMed ID: 12012968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications. In vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug; 110(2 Suppl):11-5; discussion 26-7. PubMed ID: 19667571
    [No Abstract]   [Full Text] [Related]  

  • 23. Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at Tikur Anbessa Specialized Hospital Addis Ababa, Ethiopia.
    Assefa A; Asrat D; Woldeamanuel Y; G/Hiwot Y; Abdella A; Melesse T
    Ethiop Med J; 2008 Jul; 46(3):227-35. PubMed ID: 19271386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal.
    Sire JM; Nabeth P; Perrier-Gros-Claude JD; Bahsoun I; Siby T; Macondo EA; Gaye-Diallo A; Guyomard S; Seck A; Breurec S; Garin B
    J Infect Dev Ctries; 2007 Dec; 1(3):263-8. PubMed ID: 19734603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fosfomycin tromethamine in uncomplicated urinary tract infections: a clinical study.
    Bonfiglio G; Mattina R; Lanzafame A; Cammarata E; Tempera G;
    Chemotherapy; 2005 May; 51(2-3):162-6. PubMed ID: 15886477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fosfomycin: an underrated antibiotic for urinary tract infections due to Escherichia coli].
    Garau M; Latorre A; Alonso-Sanz M
    Enferm Infecc Microbiol Clin; 2001 Dec; 19(10):462-6. PubMed ID: 11844449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
    Guneysel O; Onur O; Erdede M; Denizbasi A
    J Emerg Med; 2009 May; 36(4):338-41. PubMed ID: 18325714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.
    Smith SP; Manges AR; Riley LW
    Clin Infect Dis; 2008 Mar; 46(5):689-95. PubMed ID: 18230040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sensitivity to antibiotics of Escherichia coli strains isolated from children admitted to the "Sf. Ioan" clinical emergency hospital for children in Galaţi during 2005-2006].
    Florea C
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(1-2):37-44. PubMed ID: 18441957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
    Gobernado M; Valdés L; Alós JI; García-Rey C; Dal-Ré R; García-de-Lomas J;
    Rev Esp Quimioter; 2007 Mar; 20(1):68-76. PubMed ID: 17530038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Bacterial Spectrum and Antimicrobial Susceptibility in Female Recurrent Urinary Tract Infection: How Different They Are From Sporadic Single Episodes?
    Hisano M; Bruschini H; Nicodemo AC; Gomes CM; Lucon M; Srougi M
    Urology; 2015 Sep; 86(3):492-7. PubMed ID: 26163810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
    J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary tract infection: traditional pharmacologic therapies.
    Nicolle LE
    Am J Med; 2002 Jul; 113 Suppl 1A():35S-44S. PubMed ID: 12113870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial.
    Huttner A; Kowalczyk A; Turjeman A; Babich T; Brossier C; Eliakim-Raz N; Kosiek K; Martinez de Tejada B; Roux X; Shiber S; Theuretzbacher U; von Dach E; Yahav D; Leibovici L; Godycki-Cwirko M; Mouton JW; Harbarth S
    JAMA; 2018 May; 319(17):1781-1789. PubMed ID: 29710295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. French results of the ARESC study: clinical aspects and epidemiology of antimicrobial resistance in female patients with cystitis. Implications for empiric therapy.
    Neuzillet Y; Naber KG; Schito G; Gualco L; Botto H
    Med Mal Infect; 2012 Feb; 42(2):66-75. PubMed ID: 22264668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fosfomycin tromethamine in uncomplicated urinary tract infections: an epidemiological survey.
    Tempera G; Mirabile M; Mangiafico A; Caccamo M; Bonfiglio G
    J Chemother; 2004 Apr; 16(2):216-7. PubMed ID: 15216960
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women.
    Minassian MA; Lewis DA; Chattopadhyay D; Bovill B; Duckworth GJ; Williams JD
    Int J Antimicrob Agents; 1998 Apr; 10(1):39-47. PubMed ID: 9624542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial resistance among enterobacteriaceae causing uncomplicated urinary tract infections in Mauritius: consequences of past misuse of antibiotics.
    Issack MI; Yee Kin Tet HY; Morlat P
    J Chemother; 2007 Apr; 19(2):222-5. PubMed ID: 17434833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expanding role of fluoroquinolones.
    Schaeffer AJ
    Dis Mon; 2003 Feb; 49(2):129-47. PubMed ID: 12601342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary tract infections.
    Wang A; Nizran P; Malone MA; Riley T
    Prim Care; 2013 Sep; 40(3):687-706. PubMed ID: 23958364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.